Scott N A, Beart R W, Weiland L H, Cha S S, Lieber M M
Division of Pathology, Mayo Clinic, Rochester, Minnesota.
Br J Cancer. 1989 Jul;60(1):56-8. doi: 10.1038/bjc.1989.219.
Using flow cytometric DNA analysis of paraffin embedded tissue, DNA histograms were successfully obtained from the anal cancers of 117 patients. DNA diploid patterns were given by 82 cancers (70%) and DNA non-diploid patterns by 35 cancers (30%): 15 DNA aneuploid, 20 DNA tetraploid. Well differentiated squamous cell cancers were mainly DNA diploid, while a larger proportion of poorly differentiated and small cell cancers were DNA non-diploid. The large majority of stage A cancers were DNA diploid. A greater proportion of tumours that had invaded through the anal sphincter or had lymph node metastases or distant spread were DNA non-diploid. Prognosis was slightly poorer for patients with DNA non-diploid cancers when compared to patients with DNA diploid tumours (P = 0.08) and significantly poorer for individuals with DNA aneuploid anal cancers (P = 0.037). However, in a multivariate analysis model, the DNA ploidy pattern of an anal cancer was not of independent prognostic significance alongside tumour histology and tumour stage.
通过对石蜡包埋组织进行流式细胞术DNA分析,成功获取了117例肛管癌患者的DNA直方图。82例癌症(70%)呈现DNA二倍体模式,35例癌症(30%)呈现DNA非二倍体模式:15例为DNA非整倍体,20例为DNA四倍体。高分化鳞状细胞癌主要为DNA二倍体,而低分化和小细胞癌中较大比例为DNA非二倍体。绝大多数A期癌症为DNA二倍体。侵犯肛管括约肌、有淋巴结转移或远处转移的肿瘤中,DNA非二倍体的比例更高。与DNA二倍体肿瘤患者相比,DNA非二倍体癌症患者的预后略差(P = 0.08),而DNA非整倍体肛管癌患者的预后明显更差(P = 0.037)。然而,在多变量分析模型中,肛管癌的DNA倍体模式与肿瘤组织学和肿瘤分期相比,并无独立的预后意义。